Quick Answer
BeOne Medicines Ltd. reported Cash And Cash Equivalents At Carrying Value of $4.55 billion for the year ending 2025.
- BeOne Medicines Ltd. showed an increase of +73.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from BeOne Medicines Ltd.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: $13.37 million | Q2 2015: $25.16 million | Q3 2015: $27.45 million | Q1 2016: $208.51 million | Q2 2016: $58.08 million | Q3 2016: $85.53 million | Q1 2017: $97.75 million | Q2 2017: $261.01 million | Q3 2017: $208.51 million | Q1 2018: $490.63 million | Q2 2018: $438.42 million | Q3 2018: $643.49 million | Q1 2019: $764.49 million | Q2 2019: $918.95 million | Q3 2019: $856.85 million | Q1 2020: $1.96 billion | Q2 2020: $1.35 billion | Q3 2020: $1.46 billion | Q1 2021: $1.90 billion | Q2 2021: $1.78 billion | Q3 2021: $1.38 billion | Q1 2022: $4.35 billion | Q2 2022: $4.53 billion | Q3 2022: $4.20 billion | Q1 2023: $3.54 billion | Q2 2023: $3.41 billion | Q3 2023: $3.07 billion | Q1 2024: $2.79 billion | Q2 2024: $2.59 billion | Q3 2024: $2.70 billion | Q1 2025: $2.52 billion | Q2 2025: $2.76 billion | Q3 2025: $4.04 billion.
- Over the full 13 years of available data (2013 to 2025), BeOne Medicines Ltd.'s Cash And Cash Equivalents At Carrying Value has grown by 115,731.1%.
- Historical annual values: Fiscal year 2025: $4.55 billion | Fiscal year 2024: $2.63 billion | Fiscal year 2023: $3.17 billion | Fiscal year 2022: $3.87 billion | Fiscal year 2021: $4.38 billion | Fiscal year 2020: $1.38 billion | Fiscal year 2019: $618.01 million | Fiscal year 2018: $712.94 million | Fiscal year 2017: $239.60 million | Fiscal year 2016: $87.51 million | Fiscal year 2015: $17.87 million | Fiscal year 2014: $13.90 million | Fiscal year 2013: $3.93 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: